UNIFORM PHARMACY PRIOR AUTHORIZATION REQUEST FORM - RMHP
Castration-resistant prostate cancer with symptomatic BONE metastases and NO visceral metastases Other (please state): AWP (July 2013): Xofigo (radium Ra 223 dichloride) IV injection (1 vial): $13,800 COMMITTEE APPROVAL ... Read More
Information On Licensure Of Xofigo - Xofigo® | Licensing Site
For further information, please visit www.xofigo-us.com Please see accompanying full Prescribing Information. INDICATION Xofigo® is indicated for the treatment of patients with castration-resistant prostate ... Return Doc
Prostate Cancer Treatment Xofigo Offers Hope - YouTube
Dr. Stephen Lemon talks about the cancer drug Xofigo ( radium-223 dichloride ) for the treatment of patients with late stage prostate cancer that has spread to the bones but not to other organs, such as the lung, liver or brain, and where patients have already received treatment to lower ... View Video
This Prostate Cancer Treatment Consensus ... - MD Anderson
Consider Xofigo Consider Clinical Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA, 291:1325-1332. Tannock IF, de Wit RB, Berry WR, et al. (2004). Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer. ... Document Viewer
Hematuria (Blood In Urine): Possible Causes In Men
Blood in urine is called hematuria. Check out the common and the not so common causes of When is Blood in Urine a Symptom of Cancer? Blood In the Signs Symptoms of Prostate Cancer Symptoms of Urinary Tract Infections in Men Inguinal Hernia Decapitation and Loss of Consciousness ... Read Article
CONSENT FOR ADMINISTRATION OF RADIOACTIVE RADIUM-223 CHLORIDE ...
Treatment of prostate cancer bone metastases with the radioactive radium-223 iv. (xofigo) therapy for prostate cancer spread to bone university of virginia health system form # 130761 cat: 01-consent (orig. 07/2013) to reorder, ... Return Document
NATIONAL CANCER DRUG FUND PRIORITISATION SCORES
NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug RADIUM-223 DICHLORIDE Indication Treatment of castration-resistant prostate cancer patients with bone metastases ... Get Content Here
News Release - International Prostate Cancer Education ...
- 53/ - similar for patients treated with Xofigo and placebo. Myelosuppression – notably thrombocytopenia, neutropenia, pancytopenia, and leucopenia – has been reported in ... Fetch Content
ROC Newsletter September 2013 9 15 - Chicagocancer.com
ROC September 2013 Newsletter Radium 223 Xofigo Improves Survival for Metastatic Hormone Resistant Prostate Cancer Patients The physicians of ROC are pleased to offer Radium 223 (Xofigo, Bayer Health Care) ... View Document
Xofigo Radioactive Therapeutic Agent - UnitedHealthcare Online
Xofigo® (radium Ra 223 dichloride) injection is an alpha particle-emitting radioactive therapeutic agent indicated for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone ... View Full Source
Xofigo, INN Radium-223 Chloride - Health.gov.il
Xofigo is indicated for the treatment of adults with castration-resistant prostate cancer, symptomatic bone No cases of Xofigo-induced cancer have been reported in clinical trials in follow-up of up to three years. Reporting of suspected adverse reactions ... Return Document
Quick Reference Reimbursement Guide Hospital Outpatient
Quick Reference Reimbursement Guide Hospital Outpatient Xofigo® is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. 2. ... Retrieve Doc
Drugs Approved By The FDA In 2013 - Part 1
Food and Drug Administration approvals settled down to previous levels with just over two dozen new drugs approved in 2013. FDA announcement: FDA approves new drug for advanced prostate cancer. Product website: xofigo-us.com . 12 of 20 . Show All ... Read Article
MEDICAL POLICY LAST REVIEW . . . Radium Ra-223 Dichloride ...
Radium Ra-223 dichloride (Xofigo®) GUIDELINES This policy does not certify benefits or authorization of benefits, treatment of patients with castrate-resistant prostate cancer (CRPC) with symptomatic bone metastases, and no visceral metastases. ... Retrieve Here
Prostate Cancer Basics
A brief introduction and summary of the basics about prostate cancer. The absolute must-know information for anyone interested in prostate cancer. ... Read Article
Radium-223 Dichloride (Xofigo®) Injectable Medication ...
Radium-223 dichloride (Xofigo) Injectable Medication Precertification Request Yes No Does the patient have clinical evidence of metastasis from prostate cancer? If yes, please indicate wherethe cancer has spread: ... Fetch This Document
Radium 223 Dichloride Injection (Xofigo Useful Information ...
Radium 223 Dichloride Injection (Xofigo It is used to treat prostate cancer that is resistant to hormonal therapy. It is given to men whose cancer has spread to the bones but not to other parts of the body. It is given to men who are experiencing bone-related symptoms. ... Read More
SOLUTION FOR INJECTION Activimeter Dial Setting ... - Xofigo
Activimeter Dial Setting Procedure for Xofigo® radium Ra 223 dichloride SOLUTION FOR INJECTION InDIcAtIon Xofigo is indicated for the treatment of adults with castration-resistant prostate ... Fetch Doc
Drug: Xofigo (radium Ra 223 Dichlordie) P&T Reviewed: 6/13 ...
Xofigo is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. Criteria: ... Document Retrieval
Cáncer Colorrectal - Wikipedia, La Enciclopedia Libre
En el caso de algunos pacientes puede desarrollar anemia por falta de hierro igual que en el caso de Cancer de colon derecho es importante darse cuenta que no solo pierda sangre por las heces sino también por otros orificios del cuerpo como puede ser por los orificios nasales ... Read Article
Health Economics And Radium-223 (Xofigo®) In The Treatment Of ...
Prostate cancer (PC) is the most common cancer in Western countries, Medline (PubMed) Prostate cancer, Xofigo®, radium-223 and alpharadin 181 14 ASCO Radium-223 with prostate 94 2 ESMO Radium-223 with prostate 134 0 ... Retrieve Doc
Incorporating Xofigo® (radium Ra 223 - SignUp4
Incorporating Xofigo® (radium Ra • Review the metastatic castration‐resistant prostate cancer ... Access Document
Xofigo - Genesis Healthcare Partners
The history of prostate cancer therapy • Current treatment strategies for advanced prostate cancer • Future directions Outline of Presentation ... Return Doc
SUM-XOFIGO (radium Ra 223 Dichloride) 9 - SummaCare
Xofigo ® PA Criteria The patient has diagnosis of castration-resistant prostate cancer; AND 2) The patient has symptomatic bone metastases; AND 3) The patient has no known visceral metastatic disease Duration of Authorization: 6 months ... Get Doc
No comments:
Post a Comment